Nasdaq grts.

The following insider purchased GRTS shares in the last 24 months: Vassiliki Economides ($22,800.00). How much insider buying is happening at Gritstone bio? Insiders have purchased a total of 12,000 GRTS shares in the last 24 months for a total of $22,800.00 bought.Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train ...May 31, 2022 · EMERYVILLE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ... (Nasdaq: GRTS), and has served as its President, Chief Executive Officer, and board member since its inception in August 2015. Prior to Gritstone, in April ...

0.084%. Get the latest GRTS (GRTS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …Web

EMERYVILLE, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...The largest stake in Gritstone Oncology, Inc. (NASDAQ:GRTS) was held by Redmile Group, which reported holding $26.8 million worth of stock at the end of September.It was followed by Casdin Capital ...

If you want to know who really controls Gritstone bio, Inc. (NASDAQ:GRTS), then you'll have to look at the makeup of its share registry. We can see that retail investors own the lion's share in the company with 43% ownership. ... NasdaqGS:GRTS Earnings and Revenue Growth October 6th 2023. Our data indicates that hedge funds own 16% of …May 31, 2022 · EMERYVILLE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ... EMERYVILLE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Find the latest Institutional Holdings data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.EMERYVILLE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

Vaccine-developer Gritstone bio ( NASDAQ: GRTS) trended higher on Tuesday after B. Riley launched its coverage with a Buy rating and a 12-month target of $8 per share, noting its prospects in ...

Data for this list was collected on October 13, 2021, using TradingView’s stock screener, and all top NASDAQ genetics stocks had market caps between US$50 million and US$500 million at that time. 1.

Find the latest on short interest for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com. EMERYVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the …WebGRTS Gritstone bio Inc Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 VaccineGritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious …WebThe average price predicted for Gritstone Bio Inc (GRTS) by analysts is $10.40, which is $9.08 above the current market price. The public float for GRTS is 87.55M, and at present, short sellers hold a 9.62% of that float. On November 30, 2023, the average trading volume of GRTS was 2.33M shares. The electric vehicle boom is accelerating – …

marketbeat.com - July 5 at 5:00 AM. Gritstone bio (NASDAQ:GRTS) shareholders have endured a 70% loss from investing in the stock three years ago. finance.yahoo.com - July 4 at 10:02 AM. Board Member at Gritstone Bio Acquires Company Stock Options Worth 51,800 Shares. benzinga.com - June 22 at 11:42 PM. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that Andrew ...EMERYVILLE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Gritstone bio, Inc. Common Stock (GRTS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Web20 ม.ค. 2564 ... (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, and ...

Find the latest Insider Activity data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.

Nov 7, 2023 · About Gritstone bio Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and ... Gainers. Inpixon (NASDAQ:INPX) shares rose 44.6% to $0.2023 in pre-market trading after gaining around 10% on Wednesday.; Gritstone bio, Inc. (NASDAQ:GRTS) shares rose 37% to $1.63 in pre-market ...EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...EMERYVILLE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...About Gritstone bio Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and ...EMERYVILLE, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next …WebEMERYVILLE, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Analyzing the GRTS fundamentals. Gritstone Bio Inc [NASDAQ:GRTS] reported sales of 400.0 million for the most recent quarter, which represents a drop of -85.51%. A company’s income per employee is -$513,678 while it generates $39,781 in revenue per employee. Gross Margin for this corporation currently stands at -69.28% …Gritstone Bio Inc (NASDAQ:GRTS) trade information. After registering a 2.73% upside in the last session, Gritstone Bio Inc (GRTS) has traded red over the past five days. The stock hit a weekly high of 2.0200 this Friday, 11/03/23, jumping 2.73% in its intraday price action. The 5-day price performance for the stock is -0.53%, and -21.99% over ...

GRTS Historical Data. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online . The net and ...

Find the latest Insider Activity data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.

EMERYVILLE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Find the latest Institutional Holdings data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.Jan 9, 2022 · Insiders seem to have made the most of their holdings by selling US$221k worth of Gritstone bio, Inc. (NASDAQ:GRTS) stock at an average sell price of US$22.10 during the past year. The company's ... Find the latest Insider Activity data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com. Gritstone bio, Inc. (GRTS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 1.3700 +0.0500 (+3.79%) At close: 01:00PM EST. 1.3700 0.00 …WebGritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.EMERYVILLE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Data for this list was collected on October 13, 2021, using TradingView’s stock screener, and all top NASDAQ genetics stocks had market caps between US$50 million and US$500 million at that time. 1.The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.The largest stake in Gritstone Oncology, Inc. (NASDAQ:GRTS) was held by Redmile Group, which reported holding $26.8 million worth of stock at the end of September.It was followed by Casdin Capital ...Aug 31, 2023 · As of August 31, 2023, the average one-year price target for Gritstone Bio is 8.77. The forecasts range from a low of 2.02 to a high of $21.00. The average price target represents an increase of ... The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...

Here's Why We're Not Too Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Situation May 26. Consensus revenue estimates increase to US$46.1m May 13. First quarter 2021 earnings released: EPS US$0.10 (vs US$0.71 loss in 1Q 2020) May 07. Gritstone Oncology EPS beats by $0.41, beats on revenueGritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone ...Track Gritstone Bio Inc (GRTS) Stock Price, Quote, latest community messages, chart, news and other stock related information.Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.Instagram:https://instagram. uto zonearm holdings ticker symbolbest bank in mainepersonal loan lenders that work with chapter 7 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. how to read the spreadjordan share Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. tqqq shares EMERYVILLE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.